Page last updated: 2024-08-23

mefloquine and paclitaxel

mefloquine has been researched along with paclitaxel in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avery, VM; Sykes, ML	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Chen, TC; Golden, EB; Hofman, FM; Louie, SG; Petasis, NA; Schönthal, AH; Sharma, N; Thomas, S	1
Banu, H; Hamal, S; Jiao, S; Li, H; Li, X; Wang, X	1

Reviews

2 review(s) available for mefloquine and paclitaxel

Article	Year
Approaches to protozoan drug discovery: phenotypic screening. Journal of medicinal chemistry, 2013, Oct-24, Volume: 56, Issue:20 Topics: Drug Discovery; Humans; Molecular Structure; Neglected Diseases; Phenotype; Plasmodium falciparum; Protozoan Infections; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi	2013
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for mefloquine and paclitaxel

Article	Year
Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent. Cancer letters, 2012, Dec-30, Volume: 326, Issue:2 Topics: Antimalarials; Autophagy; Blotting, Western; Breast Neoplasms; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Endoplasmic Reticulum; Enzyme-Linked Immunosorbent Assay; Female; Humans; Mefloquine; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Ubiquitination	2012
Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway. Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:1 Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Mefloquine; Membrane Potential, Mitochondrial; Mice, SCID; Mitochondria; Neoplastic Stem Cells; Paclitaxel; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases; Uterine Cervical Neoplasms	2017

Article

Year

Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent.

Cancer letters, 2012, Dec-30, Volume: 326, Issue:2

Topics: Antimalarials; Autophagy; Blotting, Western; Breast Neoplasms; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Endoplasmic Reticulum; Enzyme-Linked Immunosorbent Assay; Female; Humans; Mefloquine; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Ubiquitination

2012

Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway.

Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:1

Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Mefloquine; Membrane Potential, Mitochondrial; Mice, SCID; Mitochondria; Neoplastic Stem Cells; Paclitaxel; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases; Uterine Cervical Neoplasms

2017